OrbiMed’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-164,627	Closed	-$6.14M	–	123
2023 Q1	$6.14M	Buy	+164,627	New	+$6.14M	0.12%	97
2022 Q1	–	Sell	-53,200	Closed	-$6.29M	–	158
2021 Q4	$6.29M	Hold	53,200	–	–	0.08%	129
2021 Q3	$7.14M	Buy	+53,200	New	+$7.14M	0.08%	143
2021 Q2	–	Sell	-72,500	Closed	-$5.82M	–	169
2021 Q1	$5.82M	Buy	+72,500	New	+$5.82M	0.05%	135
2020 Q3	–	Sell	-137,100	Closed	-$2.88M	–	150
2020 Q2	$2.88M	Sell	137,100 -125,000	-48%	-$2.63M	0.04%	125
2020 Q1	$3.21M	Hold	262,100	–	–	0.05%	114
2019 Q4	$3.85M	Sell	262,100 -65,500	-20%	-$961K	0.05%	106
2019 Q3	$4.37M	Hold	327,600	–	–	0.08%	93
2019 Q2	$5.36M	Sell	327,600 -50,000	-13%	-$819K	0.08%	102
2019 Q1	$6.45M	Hold	377,600	–	–	0.1%	97
2018 Q4	$5.15M	Sell	377,600 -367,000	-49%	-$5.01M	0.1%	96
2018 Q3	$21.3M	Sell	744,600 -131,400	-15%	-$3.76M	0.26%	86
2018 Q2	$24M	Sell	876,000 -237,000	-21%	-$6.48M	0.29%	82
2018 Q1	$23.5M	Sell	1,113,000 -1,224,684	-52%	-$25.8M	0.29%	78
2017 Q4	$44.9M	Sell	2,337,684 -324,496	-12%	-$6.24M	0.57%	51
2017 Q3	$66.2M	Hold	2,662,180	–	–	0.63%	48
2017 Q2	$42.6M	Hold	2,662,180	–	–	0.45%	61
2017 Q1	$37.5M	Hold	2,662,180	–	–	0.43%	61
2016 Q4	$34.9M	Hold	2,662,180	–	–	0.44%	55
2016 Q3	$45.3M	Hold	2,662,180	–	–	0.52%	52
2016 Q2	$56.8M	Buy	+2,662,180	New	+$56.8M	0.59%	49